PRPLvs its industry peers
A metric-by-metric comparison of PRPL against SIC 2510 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRPLEsta | — | — | — | — | — | — | — | — | — | — | — | — |
| SGI | $14.2B#1 | 26.7x#3 | 49.7x#5 | 1.9x#4 | 51.6%#3 | -0.1%#3 | 10.1%#1 | 134.4%#1 | 34.4%#1 | 6#1 | -14.4%#3 | 0.9%#4 |
| LZB | $1.3B#2 | 16.4x#2 | 1.3x#2 | 0.6x#3 | 0.8%#5 | 2.4%#2 | 6.1%#2 | 10.1%#2 | 12.8%#2 | 6#1 | 3.2%#1 | 2.9%#3 |
| CODI | $884M#3 | — | 1.9x#3 | 0.5x#1 | 4.8%#4 | -8.4%#4 | 0.6%#3 | -47.9%#5 | 0.6%#3 | — | — | 7.9%#1 |
| XMAX | $332M#4 | 10.3x#1 | 3.1x#4 | 19.9x#5 | 72.6%#2 | 38.5%#1 | -11.5%#5 | -3.2%#3 | — | — | -7.9%#2 | 0.7%#5 |
| HOFT | $155M#5 | — | 0.9x#1 | 0.6x#2 | 226.0%#1 | -115.6%#5 | -5.9%#4 | -16.0%#4 | — | 6#1 | — | 5.6%#2 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2510). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice